questionsmedicales.fr
Mélanges complexes
Produits biologiques
Vaccins
Vaccins atténués
Vaccins atténués : Questions médicales fréquentes
Termes MeSH sélectionnés :
Microbial Sensitivity Tests
Diagnostic
2
Vaccins atténués
Agents pathogènes
Immunisation
Tests sérologiques
Efficacité des vaccins
Immunité
Symptômes
2
Réactions aux vaccins
Effets secondaires
Fièvre
Maladies infectieuses
Réactions indésirables
Vaccins
Prévention
2
Préparation à la vaccination
Antécédents médicaux
Vaccins
Immunodépression
Sécurité des vaccins
Vaccins atténués
Traitements
2
Réactions allergiques
Traitement médical
Vaccins
Antécédents médicaux
Prévention
Vaccins
Complications
2
Complications
Infections
Vaccins atténués
Surveillance médicale
Effets indésirables
Vaccins
Facteurs de risque
2
Immunodépression
Grossesse
Vaccins atténués
Allergies
Évaluation médicale
Vaccins
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vaccins atténués : Questions médicales les plus fréquentes",
"headline": "Vaccins atténués : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vaccins atténués : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-19",
"dateModified": "2025-04-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vaccins atténués"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vaccins",
"url": "https://questionsmedicales.fr/mesh/D014612",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins",
"code": {
"@type": "MedicalCode",
"code": "D014612",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vaccins atténués",
"alternateName": "Vaccines, Attenuated",
"code": {
"@type": "MedicalCode",
"code": "D014613",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Aitor Nogales",
"url": "https://questionsmedicales.fr/author/Aitor%20Nogales",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. aitor_nogales@hotmail.com."
}
},
{
"@type": "Person",
"name": "Charles Grose",
"url": "https://questionsmedicales.fr/author/Charles%20Grose",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Division of Infectious Diseases/Virology Laboratory, University of Iowa, Iowa City, IA 52242, USA."
}
},
{
"@type": "Person",
"name": "Manish Patel",
"url": "https://questionsmedicales.fr/author/Manish%20Patel",
"affiliation": {
"@type": "Organization",
"name": "Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: aul3@cdc.gov."
}
},
{
"@type": "Person",
"name": "Jessie R Chung",
"url": "https://questionsmedicales.fr/author/Jessie%20R%20Chung",
"affiliation": {
"@type": "Organization",
"name": "Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia; JChung@cdc.gov."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance.",
"datePublished": "2023-07-21",
"url": "https://questionsmedicales.fr/article/37548444",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3791/64785"
}
},
{
"@type": "ScholarlyArticle",
"name": "Real world clinical feasibility of direct-from-specimen antimicrobial susceptibility testing of clinical specimens with unknown microbial load or susceptibility.",
"datePublished": "2022-11-02",
"url": "https://questionsmedicales.fr/article/36323751",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-21970-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Antibiotic Sensitivity of",
"datePublished": "2022-12-21",
"url": "https://questionsmedicales.fr/article/36628152",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/7273627"
}
},
{
"@type": "ScholarlyArticle",
"name": "Microbial Biosynthesis of Chrysazin Derivatives in Recombinant",
"datePublished": "2022-08-29",
"url": "https://questionsmedicales.fr/article/36080320",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules27175554"
}
},
{
"@type": "ScholarlyArticle",
"name": "Microbial Biofilms and Antibiofilm Agents 2.0.",
"datePublished": "2022-07-19",
"url": "https://questionsmedicales.fr/article/35887278",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms23147932"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Mélanges complexes",
"item": "https://questionsmedicales.fr/mesh/D045424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits biologiques",
"item": "https://questionsmedicales.fr/mesh/D001688"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vaccins",
"item": "https://questionsmedicales.fr/mesh/D014612"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vaccins atténués",
"item": "https://questionsmedicales.fr/mesh/D014613"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vaccins atténués - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vaccins atténués",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vaccins atténués",
"description": "Comment savoir si un vaccin est atténué ?\nQuels tests pour vérifier l'efficacité d'un vaccin atténué ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Microbial+Sensitivity+Tests#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vaccins atténués",
"description": "Quels symptômes peuvent apparaître après un vaccin atténué ?\nLes vaccins atténués causent-ils des maladies ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Microbial+Sensitivity+Tests#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vaccins atténués",
"description": "Comment se préparer avant de recevoir un vaccin atténué ?\nLes vaccins atténués sont-ils sûrs pour tous ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Microbial+Sensitivity+Tests#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vaccins atténués",
"description": "Que faire en cas de réaction sévère à un vaccin atténué ?\nLes vaccins atténués nécessitent-ils un traitement préventif ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Microbial+Sensitivity+Tests#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vaccins atténués",
"description": "Quelles complications peuvent survenir avec un vaccin atténué ?\nLes complications des vaccins atténués sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Microbial+Sensitivity+Tests#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vaccins atténués",
"description": "Qui devrait éviter les vaccins atténués ?\nLes antécédents d'allergies influencent-ils la vaccination ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Microbial+Sensitivity+Tests#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment savoir si un vaccin est atténué ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins atténués contiennent des agents pathogènes vivants, mais modifiés pour être moins virulents."
}
},
{
"@type": "Question",
"name": "Quels tests pour vérifier l'efficacité d'un vaccin atténué ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sérologiques peuvent mesurer la réponse immunitaire après vaccination."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent apparaître après un vaccin atténué ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes bénins comme fièvre légère ou douleur au site d'injection peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les vaccins atténués causent-ils des maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rarement, mais ils peuvent provoquer des symptômes légers similaires à la maladie ciblée."
}
},
{
"@type": "Question",
"name": "Comment se préparer avant de recevoir un vaccin atténué ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informez votre médecin de vos antécédents médicaux et allergies avant la vaccination."
}
},
{
"@type": "Question",
"name": "Les vaccins atténués sont-ils sûrs pour tous ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils ne conviennent pas à certaines personnes, comme celles immunodéprimées."
}
},
{
"@type": "Question",
"name": "Que faire en cas de réaction sévère à un vaccin atténué ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter immédiatement un professionnel de santé pour évaluer la situation."
}
},
{
"@type": "Question",
"name": "Les vaccins atténués nécessitent-ils un traitement préventif ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, mais des antécédents médicaux doivent être évalués avant la vaccination."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec un vaccin atténué ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications rares incluent des infections chez les personnes immunodéprimées."
}
},
{
"@type": "Question",
"name": "Les complications des vaccins atténués sont-elles fréquentes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elles sont rares et généralement bénignes, mais nécessitent une surveillance."
}
},
{
"@type": "Question",
"name": "Qui devrait éviter les vaccins atténués ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées ou enceintes doivent éviter ces vaccins."
}
},
{
"@type": "Question",
"name": "Les antécédents d'allergies influencent-ils la vaccination ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'allergies graves peuvent nécessiter une évaluation préalable."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 13/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Publications dans "Vaccins atténués" :
3 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. aitor_nogales@hotmail.com.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Division of Infectious Diseases/Virology Laboratory, University of Iowa, Iowa City, IA 52242, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: aul3@cdc.gov.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia; JChung@cdc.gov.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Biomedical Sciences and Pathobiology, Virginia Tech, VA-MD Regional College of Veterinary Medicine, Blacksburg, VA, USA. weger@vt.edu.
Center for Emerging, Zoonotic, and Arthropod-borne Pathogens, Virginia Tech, Blacksburg, VA, USA. weger@vt.edu.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. piblanlo@gmail.com.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. luis_martinez@urmc.rochester.edu.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Biosecurity Research Institute, Kansas State University, Manhattan, Kansas, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochestergrid.16416.34, Rochester, New York, USA.
Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Baylor Scott & White Health, Temple, TX, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Baylor Scott & White Health, Temple, TX, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Baylor Scott & White Health, Temple, TX, United States; Texas A&M University College of Medicine, Temple, TX, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
U.S. Centers for Disease Control and Prevention, Influenza Division, Atlanta, GA, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Texas Biomedical Research Institute, San Antonio, TX, USA. Electronic address: lmartinez@txbiomed.org.
Publications dans "Vaccins atténués" :
To improve the efficiency of antimicrobial susceptibility testing (AST) and phage high-throughput screening for resistant bacteria and to reduce the detection cost, an intelligent high-throughput AST/...
Within healthcare settings, physicians use antibiograms, which offer information on local susceptibility rates, as an aid in selecting empirical antibiotic therapy and avoiding the prescription of pot...
The study's objective was to determine...
Nonrepetitive...
A total of 317 patients were reviewed: 202 females (63.7%) and 115 males (36.3%)....
Highly effective antibiotics such as cefoxitin and ceftazidime should be used empirically by considering antibiotic sensitivity changes by sex, season, and year. Regional studies should be conducted f...
Anthraquinone and its derivatives show remarkable biological properties such as anticancer, antibacterial, antifungal, and antiviral activities. Hence, anthraquinones derivatives have been of prime in...
It is estimated that <0 [...]...
Gram-negative (GN) sepsis is a medical emergency where management in resource-limited settings relies on conventional microbiological culture techniques providing results in 3-4 days. Recognizing this...
Patients with myasthenia gravis (MG) are prone to the development of pneumonia due to the long-term immunotherapies they receive and a tendency for aspiration. Pneumonia remains a risk factor for MG w...
Between January 2013 and October 2022, we performed an inpatient database review for MG patients with pneumonia concurrence in a tertiary research center specializing in neuromuscular disorders. The c...
In our cohort, 90.32% (112/124) of organisms were bacteria and 42.86% (48/112) of pathogenic bacteria were carbapenem-resistant. A high abundance of Epstein-Barr virus (EBV) was detected using next-ge...
Our identification of the microbial etiology of pneumonia in MG patients may provide future perspectives on accurate antibiotic options and enable early interventions when risk factors are present....
Early diagnosis and treatment are important for a good prognosis of bloodstream infections. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) recommends rapid antimicrobial susce...
Twenty strains of...
For...
EUCAST-RAST for...
Microbial keratitis (MK) is a significant cause of blindness in sub-Saharan Africa. We investigated the feasibility of using a novel corneal impression membrane (CIM) for obtaining and processing samp...
Samples were collected from patients presenting with suspected MK using a 12 mm diameter polytetrafluoroethylene CIM disc. Samples were processed using culture and PCR for...
71 eyes of 71 patients were included. The overall CIM isolation rate was 81.7% (58 positive samples from 71 participants). 69 (81.2%) of isolates were Gram-positive cocci. Coagulase-negative...
In a resource-poor setting, a CIM can be used to safely sample the cornea in patients presenting with suspected MK, enabling identification of causative microorganisms by culture and PCR. Although the...
Microbial persisters are defined as the tiny sub-population of microorganisms that develop intrinsic strategies for survival with high tolerance to various antimicrobials. Currently, persister researc...